Eva-Maria Becker

USPTO Granted Patents = 25 (Patent Applications = 7)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 12)

Average Co-Inventor Count = 12.0

ph-index = 8

Forward Citations = 188(Granted Patents)

Company Filing History:

11 out of 721

Bayer Intellectual Property Gmbh

patents

7 out of 378

Bayer Pharma Aktiengesellschaft

Bayer Schering Pharma Ag

patents

5. 1 out of 76

Bayer Healthcare Aktiengesellschaft

patents

Years Active: 2009-2024

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12064429 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2024-08-20),

2. 11439642 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2022-09-13),

3. 10736896 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2020-08-11),

4. 10053428 - 5-aminotetrahydroquinoline-2-carboxylic acids and their use (2018-08-21),

5. 9993476 - Substituted 5-flouro-1H-pyrazolopyridines and their use (2018-06-12),

6. 9688636 - 5-aminotetrahydroquinoline-2-carboxylic acids and their use (2017-06-27),

7. 9266885 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2016-02-23),

8. 9126998 - Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use (2015-09-08),

9. 9018258 - Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof (2015-04-28),

10. 8987256 - Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof (2015-03-24),

11. 8981104 - 5-aminotetrahydroquinoline-2-carboxylic acids and their use (2015-03-17),

12. 8921377 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2014-12-30),

13. 8796335 - Branched 3-phenylpropionic acid derivatives and their use (2014-08-05),

14. 8778964 - Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use (2014-07-15),

15. 8642592 - Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof (2014-02-04),

Title: Eva-Maria Becker: Innovator in Cardiovascular Treatments

Introduction

Eva-Maria Becker, based in Wuppertal, Germany, is a prominent inventor with an impressive portfolio of 25 patents. Her contributions to the field of medicinal chemistry, particularly regarding cardiovascular disorders, have paved the way for advancements in treatment methodologies.

Latest Patents

Among her latest inventions are the novel substituted 5-fluoro-1H-pyrazolopyridines. These patents pertain to their preparation, use alone or in combination for the treatment and/or prophylaxis of various diseases. Specifically, they are designed for producing medicaments aimed at treating cardiovascular disorders. This innovative approach signifies not only a step forward in pharmaceutical development but also emphasizes the potential of these compounds in managing serious health conditions.

Career Highlights

Eva-Maria Becker has had a notable career, having worked in prominent companies such as Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. Her time at these institutions has allowed her to hone her skills and contribute meaningfully to research and development in the pharmaceutical sector.

Collaborations

Throughout her career, Eva-Maria has collaborated with esteemed colleagues like Johannes-Peter Stasch and Frank Wunder. These partnerships have been integral in fostering an environment of innovation and sharing expertise, crucial for the successful advancement of her research and patent applications.

Conclusion

In summary, Eva-Maria Becker's contributions to medicine through her patents and collaborations reflect her dedication to improving treatment options for cardiovascular disorders. Her ongoing work in the field continues to inspire future innovations and highlights the vital role inventors play in healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.